DS

Divyalata Singh

Active Director Director DIN 08338071
DIN 08338071 First appointment Jan 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2019
Shareholding value •••• Premium profile

About Divyalata Singh

Data last updated:

Divyalata Singh is a Director at Zenacia Life Sciences Private Limited (since 2019). The company operates in Pharma. Zenacia Life Sciences Private Limited reported revenue of ₹5.8 Lakh (FY 2021).

DIN 08338071
Primary Designation Director
Industry Pharma
First Appointment 11 Jan 2019
Oldest Company Age 11 yrs
Largest company Zenacia Life Sciences Private Limited · ₹5.8 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Jan 20192015₹5.8 Lakh (FY 2021)Active

Board colleagues of Divyalata Singh

NameDINCompanyDesignation
Kuldeep Singh07245206Zenacia Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zenacia Life Sciences Private Limited
Premium access

Shareholding and investment profile for Divyalata Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Divyalata Singh

Divyalata Singh currently holds 1 directorship: Zenacia Life Sciences Private Limited (Director, since 11 Jan 2019, revenue ₹5.8 Lakh (FY 2021)).

Divyalata Singh was first appointed on 11 Jan 2019 as Director at Zenacia Life Sciences Private Limited.

The current boards of Divyalata Singh's companies include Kuldeep Singh (Zenacia Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available